UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004647 |
|---|---|
| Receipt number | R000005539 |
| Scientific Title | Phase II clinical trial of third-line Panitumumab and irinotecan or Panitumumab therapy for patients with KRAS wild-type unresectable/recurrent colorectal cancer |
| Date of disclosure of the study information | 2010/12/01 |
| Last modified on | 2012/05/08 16:19:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/12/01 16:53:14 | ||
| 2 | Update | 2011/06/01 11:24:55 | Institutions |
|
| 3 | Update | 2011/06/01 11:35:01 | Key secondary outcomes |
|
| 4 | Update | 2012/05/08 16:18:22 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2012/05/08 16:19:40 | Recruitment status |
